Affirm Q4 2026 Earnings Beat, Raises Q1 Revenue View

Affirm Q4 2026 earnings beat and management raised near-term revenue guidance as GMV and Card adoption accelerated, lifting after-hours shares.

August 27, 2026·2 min read
View all news articles
Flat vector of a payments card fused with an expanding server stack, reflecting Affirm Q4 2026 earnings and GMV acceleration.

KEY TAKEAWAYS

  • Following the filing, Q4 revenue was $1.2 billion, topping $1.1 billion consensus.
  • Management raised next-quarter revenue guidance to $1.19-$1.22 billion, citing GMV and Card adoption.
  • GMV reached $14.1 billion, up 36%, with Affirm Card GMV surging 124% to $2.8 billion.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Affirm Holdings, Inc. (NASDAQ: AFRM) reported fiscal Q4 2026 earnings on Aug. 27, 2026, that exceeded management guidance for the quarter ended June 30, 2026. The company raised its near-term revenue outlook, citing accelerating gross merchandise volume (GMV) and increased Affirm Card usage as key drivers.

Q4 Results and Guidance

Affirm filed a shareholder letter as Exhibit 99.1 on Form 8-K dated Aug. 25, 2026, and issued a press release announcing that the quarter’s results were posted on its investor relations site. The filing noted the inclusion of non-GAAP financial measures and reconciliations to GAAP.

For the quarter ended June 30, 2026, Affirm reported revenue of $1.17 billion, surpassing analyst consensus of $1.11 billion. GAAP net income reached $1.62 billion, or $4.62 per share, compared with consensus EPS of $0.33. Adjusted operating income margin rose 3 percentage points year over year to 30%. The company set revenue guidance for the quarter ending September 2026 at $1.19 billion to $1.22 billion. For fiscal 2026, Affirm reported revenue of $4.26 billion and GAAP net income of $1.93 billion, or $5.53 per share.

A valuation allowance release on most domestic deferred tax assets materially boosted the reported GAAP net income for the quarter.

GMV and Card Acceleration

Affirm’s GMV for Q4 2026 reached $14.1 billion, up 36% year over year, marking the 11th consecutive quarter with GMV growth of 30% or more. Revenue less transaction costs increased 39% to $589 million, while total transactions rose 41% to 53 million.

Active merchants grew more than 50% year over year to 571,000, doubling the growth rate from the prior year. Active consumers increased 21% to 27.8 million. Affirm Card GMV surged 124% to $2.8 billion, and active cardholders more than doubled to 5.2 million. Direct-to-consumer GMV, driven entirely by the Affirm Card, rose 49% to $4.7 billion.

This combination of expanding merchant partnerships, rising consumer activity, and rapid Affirm Card adoption supported management’s raised near-term revenue guidance.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Gap Earnings Lift Outlook as Old Navy Weakens

Gap Earnings Lift Outlook as Old Navy Weakens

Gap earnings had tariff refunds that lifted margins and EPS guidance, leaving traders to question guidance durability despite $726 million returned.

Marvell Earnings Beat, Guides Higher

Marvell Earnings Beat, Guides Higher

Marvell earnings beat and guided Q3 revenue above consensus, citing strong AI data-center demand and likely prompting trader reweighting.

Ulta Beauty Earnings Beat, Raises 2026 Guidance

Ulta Beauty Earnings Beat, Raises 2026 Guidance

Ulta Beauty earnings beat estimates and lifted fiscal 2026 EPS guidance to $28.70-$29.00, raising buybacks to $1.8 billion and tightening positioning.

Build-A-Bear Cuts Outlook, Fires Executive

Build-A-Bear Cuts Outlook, Fires Executive

Build-A-Bear cuts outlook after Q2 sales decline and trims fiscal 2026 revenue to $500M-$525M and pre-tax income to $60M-$68M, likely pressuring shares.

Novo Nordisk Downgrade to Sell by Deutsche Bank

Novo Nordisk Downgrade to Sell by Deutsche Bank

Novo Nordisk downgrade by Deutsche Bank cut the target, citing slowing 2027 growth, pipeline failure and patent-cliff risk, pressuring shares.

Wendy's Take-Private Hopes Fade After Trian Pause WEN

Wendy's Take-Private Hopes Fade After Trian Pause WEN

Reuters said Trian has no plans for a Wendy's take-private, erasing a deal premium and shifting traders' focus back to Wendy's turnaround and peer risks.